Transforming Neurological Care in 30 Seconds with QDG Health
Summary
QDG Health, developed by Dr. Helen Bronte-Stewart at Stanford, introduces Quantitative Digitography (QDG), a 30-second finger-tapping test using the KeyDuo device to remotely monitor Parkinson’s disease (PD) symptoms. Its AI-driven PRECISE algorithm translates movement data into validated motor biomarkers, tracking tremors, rigidity, and bradykinesia with high accuracy. The system enables real-time symptom monitoring, medication response tracking, and deep brain stimulation (DBS) evaluations—reducing clinic visits and improving accessibility. QDG also enhances clinical trials by providing high-resolution, objective PD assessments, expediting drug development. Recently designated as an FDA Breakthrough Device, QDG Health represents a game-changing innovation in precision neurology.